Publication | Closed Access

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

Open-label TrialHepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyTreatment-experienced PatientsGenotype 4Infection ControlAntiviral DrugChronic Viral InfectionMedicine